Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer.
James E HanKaveh ZakeriGabriel RaabJennifer HesseAchraf ShamseddineLinda ChenYao YuJung Julie KangSean M McBrideNadeem RiazChiaojung Jillian TsaiDaphna GelblumEric J ShermanRichard J WongLoren MichelNancy Y LeePublished in: Head & neck (2023)
Chemoradiation with carboplatin and paclitaxel is an excellent option for cisplatin-ineligible HNSCC patients.